Kepos Capital’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Kepos Capital’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,000	Closed	-$121K	–	718
2021 Q3	$121K	Buy	+35,000	New	+$108K	0.01%	523

Other funds holding SLGCW

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kepos Capital's SLGCW Position: Q4 2021 in Review

Kepos Capital sold out of SomaLogic, Inc. Warrant (SLGCW) in Q4 2021, closing a stake of 35,000 shares — an estimated $121K sold.

Kepos Capital first reported a position in SLGCW in Q3 2021 and held it in 1 quarter. The position peaked at $121K in Q3 2021. 34 funds tracked by Wall St. Rank hold SLGCW as of Q4 2021.

Kepos Capital reported no remaining SomaLogic, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
Kepos Capital sold 35,000 SomaLogic, Inc. Warrant shares in Q4 2021, an estimated $121K.
Kepos Capital first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 1 quarter.
Kepos Capital's SomaLogic, Inc. Warrant position peaked at $121K in Q3 2021.
34 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q4 2021.

Based on Kepos Capital's 13F filing for Q4 2021, filed 14 Feb 2022.